{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:27:28Z","timestamp":1793993248475,"version":"4.8.0"},"reference-count":232,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA185148"],"award-info":[{"award-number":["U01 CA185148"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA200466"],"award-info":[{"award-number":["U01 CA200466"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA210240"],"award-info":[{"award-number":["U01 CA210240"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 CA1213862"],"award-info":[{"award-number":["U01 CA1213862"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA195586"],"award-info":[{"award-number":["R01 CA195586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA218545"],"award-info":[{"award-number":["R01 CA218545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bbcan.2020.188359","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T02:35:05Z","timestamp":1585103705000},"page":"188359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions"],"prefix":"10.1016","volume":"1873","author":[{"given":"Jawed A.","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Pothuraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd W.","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2020.188359_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.bbcan.2020.188359_bb0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0884533617722986","article-title":"Cancer Cachexia: Cause, Diagnosis, and Treatment","volume":"32","author":"Mattox","year":"2017","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.bbcan.2020.188359_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1758834017698643","article-title":"Cancer-induced muscle wasting: latest findings in prevention and treatment","volume":"9","author":"Aversa","year":"2017","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081206","article-title":"Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib","volume":"11","author":"Imai","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12524","article-title":"Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer","author":"Huang","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00277-013-1881-3","article-title":"Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study","volume":"93","author":"Vermaete","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0040","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbcan.2020.188359_bb0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jgo.2017.08.013","article-title":"Pearls of optimizing nutrition and physical performance of older adults undergoing cancer therapy","volume":"8","author":"Vigano","year":"2017","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121861","article-title":"Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review","volume":"11","author":"Dunne","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0060","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb0065","doi-asserted-by":"crossref","first-page":"212265","DOI":"10.7573\/dic.212265","article-title":"One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA","volume":"3","author":"Arthur","year":"2014","journal-title":"Drugs Context"},{"key":"10.1016\/j.bbcan.2020.188359_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.seminoncol.2014.02.005","article-title":"Tumor macroenvironment and metabolism","volume":"41","author":"Al-Zoughbi","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbcan.2020.188359_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clnu.2009.07.001","article-title":"Resting energy expenditure and body composition in patients with newly detected cancer","volume":"29","author":"Cao","year":"2010","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbcan.2020.188359_bb0090","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3945\/ajcn.116.140434","article-title":"Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy","volume":"105","author":"Vazeille","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbcan.2020.188359_bb0095","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: how does it benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2020.188359_bb0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between Metabolism and Cancer Biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2020.188359_bb0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/febs.14358","article-title":"ER stress in skeletal muscle remodeling and myopathies","volume":"286","author":"Afroze","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.bbcan.2020.188359_bb0120","doi-asserted-by":"crossref","first-page":"11315","DOI":"10.1002\/jcp.27789","article-title":"Endoplasmic reticulum stress and unfolded protein response profile in quadriceps of sarcopenic patients with respiratory diseases","volume":"234","author":"Barreiro","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121929","article-title":"ER Stress and Unfolded Protein Response in Cancer Cachexia","volume":"11","author":"Roy","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.trecan.2019.07.010","article-title":"Impaired Muscle Regeneration in Cancer-Associated Cachexia","volume":"5","author":"Arneson","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2020.188359_bb0135","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2020.188359_bb0140","first-page":"E996","article-title":"Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma","volume":"268","author":"Baracos","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbcan.2020.188359_bb0145","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1073\/pnas.95.21.12602","article-title":"Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway","volume":"95","author":"Solomon","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2020.188359_bb0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","article-title":"The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle","volume":"6","author":"Clarke","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0155","first-page":"225","article-title":"Signaling pathways perturbing muscle mass","volume":"13","author":"Glass","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbcan.2020.188359_bb0160","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2020.188359_bb0165","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2020.188359_bb0170","first-page":"5568","article-title":"Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats","volume":"54","author":"Temparis","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0175","doi-asserted-by":"crossref","first-page":"227S","DOI":"10.1093\/jn\/129.1.227S","article-title":"Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states","volume":"129","author":"Lecker","year":"1999","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbcan.2020.188359_bb0180","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.celrep.2019.06.094","article-title":"A Key Role for the Ubiquitin Ligase UBR4 in Myofiber Hypertrophy in Drosophila and Mice","volume":"28","author":"Hunt","year":"2019","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188359_bb0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ajcn\/nqz347","article-title":"The autophagic-lysosomal and ubiquitin proteasome systems are simultaneously activated in the skeletal muscle of gastric cancer patients with cachexia","volume":"111","author":"Zhang","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbcan.2020.188359_bb0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","article-title":"Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2020.188359_bb0195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jcsm.12498","article-title":"Derangements of amino acids in cachectic skeletal muscle are caused by mitochondrial dysfunction","volume":"11","author":"Kunzke","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb0200","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3278","article-title":"Muscle disorders: preventing wastage","volume":"9","author":"Tse","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2020.188359_bb0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/gyno.2001.6350","article-title":"Production of activin A in hyperplasia and adenocarcinoma of the human endometrium","volume":"83","author":"Otani","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.49.3.409","article-title":"Overexpression of activin A in stage IV colorectal cancer","volume":"49","author":"Wildi","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2020.188359_bb0215","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0220","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"Reed","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2020.188359_bb0225","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0230","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ng.2772","article-title":"BMP signaling controls muscle mass","volume":"45","author":"Sartori","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2020.188359_bb0235","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1126\/science.1069525","article-title":"Induction of cachexia in mice by systemically administered myostatin","volume":"296","author":"Zimmers","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2020.188359_bb0240","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0245","doi-asserted-by":"crossref","first-page":"9306","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188359_bb0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jcsm.12489","article-title":"Autocrine activin A signaling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia","volume":"11","author":"Pettersen","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb0255","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0260","first-page":"R659","article-title":"Cachectin\/TNF or IL-1 alpha induces cachexia with redistribution of body proteins","volume":"256","author":"Fong","year":"1989","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbcan.2020.188359_bb0265","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","article-title":"NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia","volume":"289","author":"Guttridge","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2020.188359_bb0270","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200420174","article-title":"Cancer cachexia is regulated by selective targeting of skeletal muscle gene products","volume":"114","author":"Acharyya","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0275","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0280","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","article-title":"IKKbeta\/NF-kappaB activation causes severe muscle wasting in mice","volume":"119","author":"Cai","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0290","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00109-004-0555-y","article-title":"Nuclear factor-kappaB: its role in health and disease","volume":"82","author":"Kumar","year":"2004","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0295","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0300","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/onc.2016.437","article-title":"Blockade of the IL-6 trans-signaling\/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma","volume":"36","author":"Miller","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2020.188359_bb0305","doi-asserted-by":"crossref","first-page":"39640","DOI":"10.18632\/oncotarget.17387","article-title":"Pantoprazole blocks the JAK2\/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2020.188359_bb0310","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10637-018-0580-2","article-title":"Ruxolitinib + capecitabine in advanced\/metastatic pancreatic cancer after disease progression\/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies","volume":"36","author":"Hurwitz","year":"2018","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.bbcan.2020.188359_bb0315","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI118968","article-title":"Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription","volume":"98","author":"Price","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0320","first-page":"R674","article-title":"IGF-1 is downregulated in experimental cancer cachexia","volume":"291","author":"Costelli","year":"2006","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.bbcan.2020.188359_bb0325","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","article-title":"Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways","volume":"3","author":"Rommel","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0330","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0092-8674(00)80799-0","article-title":"Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4","volume":"97","author":"Bohni","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0335","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/mend.14.6.0446","article-title":"A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1","volume":"14","author":"Haruta","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0340","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/MCB.20.5.1489-1496.2000","article-title":"Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3\u2019-kinase inhibition","volume":"20","author":"Lee","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0345","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/MCB.22.4.1016-1026.2002","article-title":"Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1","volume":"22","author":"Zhande","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0350","doi-asserted-by":"crossref","first-page":"9295","DOI":"10.1128\/MCB.24.21.9295-9304.2004","article-title":"Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy","volume":"24","author":"Lai","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0355","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.00073.2004","article-title":"IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1","volume":"287","author":"Sacheck","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0360","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2020.188359_bb0365","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/MCB.01347-08","article-title":"Ubiquitin ligase Cbl-b is a negative regulator for insulin-like growth factor 1 signaling during muscle atrophy caused by unloading","volume":"29","author":"Nakao","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0370","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nature11834","article-title":"Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders","volume":"494","author":"Song","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2020.188359_bb0375","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/ncomms3354","article-title":"MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signaling","volume":"4","author":"Yi","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2020.188359_bb0380","first-page":"647","article-title":"Altered insulin response to glucose in weight-losing cancer patients","volume":"14","author":"Rofe","year":"1994","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0385","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrc2507","article-title":"Cytokines and their relationship to the symptoms and outcome of cancer","volume":"8","author":"Seruga","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2020.188359_bb0390","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-2895-8_7","article-title":"Glucocorticoids and Skeletal Muscle","volume":"872","author":"Bodine","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0400","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0405","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bbcan.2020.188359_bb0410","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1096\/fj.13-230375","article-title":"Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle","volume":"27","author":"Braun","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2020.188359_bb0415","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0304-3835(95)04026-9","article-title":"Muscle hypercatabolism during cancer cachexia is not reversed by the glucocorticoid receptor antagonist RU38486","volume":"99","author":"Llovera","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2020.188359_bb0420","first-page":"R1165","article-title":"NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes","volume":"279","author":"Li","year":"2000","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.bbcan.2020.188359_bb0425","first-page":"871","article-title":"Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha","volume":"12","author":"Li","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.bbcan.2020.188359_bb0430","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumors secreting human TNF\/cachectin induce cachexia in mice","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb0435","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1152\/ajpendo.00359.2006","article-title":"Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle","volume":"292","author":"Frost","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0440","doi-asserted-by":"crossref","first-page":"C986","DOI":"10.1152\/ajpcell.00041.2008","article-title":"TNF induction of atrogin-1\/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1\/3 signaling","volume":"295","author":"Moylan","year":"2008","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0445","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cyto.2011.01.009","article-title":"Tumor necrosis factor alpha (TNF-alpha) inactivates the PI3-kinase\/PKB pathway and induces atrophy and apoptosis in L6 myotubes","volume":"54","author":"Sishi","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.bbcan.2020.188359_bb0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00926829","article-title":"Acute treatment with tumor necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle","volume":"125","author":"Garcia-Martinez","year":"1993","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2020.188359_bb0455","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1006\/bbrc.1998.9794","article-title":"Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle","volume":"253","author":"Noguchi","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2020.188359_bb0460","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0465","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbalip.2015.08.008","article-title":"Regulation of hepatic cardiolipin metabolism by TNFalpha: Implication in cancer cachexia","volume":"1851","author":"Peyta","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2020.188359_bb0470","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","article-title":"Role of interleukin-6 in cachexia: therapeutic implications","volume":"8","author":"Narsale","year":"2014","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"10.1016\/j.bbcan.2020.188359_bb0475","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI118398","article-title":"Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice","volume":"97","author":"Tsujinaka","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0480","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","article-title":"A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer","volume":"11","author":"Bayliss","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.bbcan.2020.188359_bb0485","first-page":"R393","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"key":"10.1016\/j.bbcan.2020.188359_bb0490","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1210\/jc.2007-2223","article-title":"Interleukin-6 markedly decreases skeletal muscle protein turnover and increases nonmuscle amino acid utilization in healthy individuals","volume":"93","author":"van Hall","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0495","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00424-008-0574-6","article-title":"Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc (Min\/+) mouse","volume":"457","author":"Baltgalvis","year":"2009","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbcan.2020.188359_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbcan.2020.188359_bb0505","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2826.2009.01879.x","article-title":"Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei","volume":"21","author":"Benrick","year":"2009","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0510","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3109\/0886022X.2010.504910","article-title":"Anorexia, fatigue, and plasma interleukin-6 levels in chronic hemodialysis patients","volume":"32","author":"Bossola","year":"2010","journal-title":"Ren. Fail."},{"key":"10.1016\/j.bbcan.2020.188359_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121863","article-title":"IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1\/2 Axis to Induce Muscle Atrophy","volume":"11","author":"Callaway","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0520","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/jcp.22196","article-title":"Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer","volume":"224","author":"Mimeault","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0525","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1743-7075-7-34","article-title":"Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation","volume":"7","author":"Dostalova","year":"2010","journal-title":"Nutr. Metab. (Lond.)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0530","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/j.bbcan.2020.188359_bb0535","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1038\/s41366-019-0365-5","article-title":"GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP\/NTS","volume":"43","author":"Tsai","year":"2019","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.bbcan.2020.188359_bb0540","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/nm.4393","article-title":"The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL","volume":"23","author":"Emmerson","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0545","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature24042","article-title":"Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15","volume":"550","author":"Hsu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2020.188359_bb0550","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/nm.4392","article-title":"GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates","volume":"23","author":"Mullican","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0555","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1038\/nm.4394","article-title":"GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand","volume":"23","author":"Yang","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0560","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tem.2018.05.002","article-title":"Uniting GDF15 and GFRAL: therapeutic opportunities in Obesity and Beyond","volume":"29","author":"Mullican","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0565","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating Activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb0570","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","article-title":"Biomarkers of cancer cachexia","volume":"50","author":"Loumaye","year":"2017","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbcan.2020.188359_bb0575","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2353\/ajpath.2006.051316","article-title":"Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy","volume":"168","author":"Parsons","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0580","doi-asserted-by":"crossref","first-page":"531","DOI":"10.15252\/emmm.201607231","article-title":"Supraphysiological levels of GDF11 induce striated muscle atrophy","volume":"9","author":"Hammers","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0585","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/CIRCRESAHA.118.312955","article-title":"GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death","volume":"123","author":"Harper","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0590","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1172\/JCI26239","article-title":"Osteoblast-derived PTHrP is a physiological regulator of bone formation","volume":"115","author":"Martin","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0595","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumor-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2020.188359_bb0600","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cmet.2015.11.003","article-title":"PTH\/PTHrP Receptor Mediates Cachexia in Models of Kidney Failure and Cancer","volume":"23","author":"Kir","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0605","first-page":"153","article-title":"Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting","volume":"20","author":"Thomas","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.bbcan.2020.188359_bb0610","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1158\/0008-5472.CAN-06-4585","article-title":"Mechanism of increased lipolysis in cancer cachexia","volume":"67","author":"Agustsson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0615","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1111\/febs.14182","article-title":"Functionality of intrinsic disorder in tumor necrosis factor-alpha and its receptors","volume":"284","author":"Uversky","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.bbcan.2020.188359_bb0620","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fendo.2016.00030","article-title":"Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders","volume":"7","author":"Choe","year":"2016","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0625","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2015.00158","article-title":"A New Role for Browning as a Redox and Stress Adaptive Mechanism?","volume":"6","author":"Jeanson","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0630","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.276733.115","article-title":"Mechanisms of metabolic dysfunction in cancer-associated cachexia","volume":"30","author":"Petruzzelli","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2020.188359_bb0635","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb0640","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/bjc.1996.294","article-title":"The relationship between weight loss and interleukin 6 in non-small-cell lung cancer","volume":"73","author":"Scott","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2020.188359_bb0645","first-page":"1091","article-title":"Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival","volume":"21","author":"Moses","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2020.188359_bb0650","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","article-title":"Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning","volume":"17","author":"Han","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"Pt 2","key":"10.1016\/j.bbcan.2020.188359_bb0655","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signaling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbcan.2020.188359_bb0660","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121221","article-title":"Cachexia-associated adipose loss induced by tumor-secreted leukemia inhibitory factor is counterbalanced by decreased leptin","volume":"3","author":"Arora","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2020.188359_bb0665","doi-asserted-by":"crossref","first-page":"820934","DOI":"10.1155\/2015\/820934","article-title":"Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia","volume":"2015","author":"Ebadi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbcan.2020.188359_bb0670","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13046-018-0963-4","article-title":"Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting","volume":"37","author":"Pothuraju","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0675","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.26811","article-title":"Adipose tissue dysfunction in cancer cachexia","volume":"234","author":"Daas","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0680","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1101\/gad.211649.112","article-title":"Adaptive thermogenesis in adipocytes: is beige the new brown?","volume":"27","author":"Wu","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2020.188359_bb0685","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0690","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0889-1605(86)80012-X","article-title":"The effect of intermittent cold treatment on the adipose tissue of the cat. Apparent transformation from white to brown adipose tissue","volume":"97","author":"Loncar","year":"1986","journal-title":"J. Ultrastruct. Mol. Struct. Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0695","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cmet.2011.06.020","article-title":"White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis","volume":"14","author":"Cao","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0700","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1186034","article-title":"Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes","volume":"328","author":"Vegiopoulos","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2020.188359_bb0705","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1172\/JCI67803","article-title":"Recruited brown adipose tissue as an antiobesity agent in humans","volume":"123","author":"Yoneshiro","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0710","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0715","first-page":"3084","article-title":"Interleukin 1 alpha increases serum leptin concentrations in humans","volume":"82","author":"Janik","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0720","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1084\/jem.185.1.171","article-title":"Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia","volume":"185","author":"Sarraf","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0725","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.critrevonc.2013.07.015","article-title":"Clinical evaluation and optimal management of cancer cachexia","volume":"88","author":"Tuca","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0730","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/en.2002-221099","article-title":"Differential role of melanocortin receptor subtypes in cachexia","volume":"144","author":"Marks","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2020.188359_bb0735","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1210\/en.2007-0017","article-title":"Regulation of central melanocortin signaling by interleukin-1 beta","volume":"148","author":"Scarlett","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2020.188359_bb0740","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1210\/endo.142.8.8324","article-title":"Reversal of cancer anorexia by blockade of central melanocortin receptors in rats","volume":"142","author":"Wisse","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2020.188359_bb0745","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1126\/science.1072327","article-title":"Activation of central melanocortin pathways by fenfluramine","volume":"297","author":"Heisler","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2020.188359_bb0750","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12976-015-0015-0","article-title":"Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia","volume":"12","author":"Friesen","year":"2015","journal-title":"Theor. Biol. Med. Model"},{"key":"10.1016\/j.bbcan.2020.188359_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119888","article-title":"Liver inflammation and metabolic signaling in ApcMin\/+ mice: the role of cachexia progression","volume":"10","author":"Narsale","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbcan.2020.188359_bb0760","first-page":"363","article-title":"Liver macrophages contribute to pancreatic cancer-related cachexia","volume":"21","author":"Martignoni","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2020.188359_bb0765","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","article-title":"Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes","volume":"242","author":"Castell","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2020.188359_bb0770","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.29420","article-title":"Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis","volume":"66","author":"Bhanji","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2020.188359_bb0775","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/hep.22383","article-title":"Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice","volume":"48","author":"Berriel Diaz","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbcan.2020.188359_bb0780","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/emmm.201201869","article-title":"TSC22D4 is a molecular output of hepatic wasting metabolism","volume":"5","author":"Jones","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0785","article-title":"Hepatic alterations during the development and progression of cancer cachexia","author":"Rosa-Caldwell","year":"2019","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"10.1016\/j.bbcan.2020.188359_bb0790","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice","volume":"126","author":"Asp","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2020.188359_bb0795","first-page":"E1033","article-title":"Insulin secretion in Walker 256 tumor cachexia","volume":"258","author":"Fernandes","year":"1990","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbcan.2020.188359_bb0800","first-page":"C804","article-title":"Impairment of insulin secretion in pancreatic islets isolated from Walker 256 tumor-bearing rats","volume":"271","author":"el Razi Neto","year":"1996","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.bbcan.2020.188359_bb0805","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","article-title":"Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning","volume":"13","author":"Lundholm","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0810","series-title":"Energy metabolism in cachexia, EMBO Rep, 20","author":"Rohm","year":"2019"},{"key":"10.1016\/j.bbcan.2020.188359_bb0815","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut barrier dysfunction in the Apc(Min\/+) mouse model of colon cancer cachexia","volume":"1812","author":"Puppa","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2020.188359_bb0820","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.18632\/oncotarget.24804","article-title":"Increased gut permeability in cancer cachexia: mechanisms and clinical relevance","volume":"9","author":"Bindels","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2020.188359_bb0825","first-page":"774","article-title":"Increased plasma ghrelin level in lung cancer cachexia","volume":"9","author":"Shimizu","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0830","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbcan.2017.02.002","article-title":"Ghrelin and cancer progression","volume":"1868","author":"Lin","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbcan.2020.188359_bb0835","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ctrv.2015.09.002","article-title":"Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist","volume":"41","author":"Esposito","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2020.188359_bb0840","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1172\/JCI200421134","article-title":"Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells","volume":"114","author":"Dixit","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0845","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumor- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb0850","first-page":"611","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","volume":"123","author":"Porporato","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0855","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia","volume":"10","author":"Bindels","year":"2016","journal-title":"ISME J."},{"key":"10.1016\/j.bbcan.2020.188359_bb0860","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.biocel.2013.06.021","article-title":"Muscle wasting: the gut microbiota as a new therapeutic target?","volume":"45","author":"Bindels","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0865","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrendo.2011.126","article-title":"Targeting gut microbiota in obesity: effects of prebiotics and probiotics","volume":"7","author":"Delzenne","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0870","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ydbio.2011.06.002","article-title":"Growth of limb muscle is dependent on skeletal-derived Indian hedgehog","volume":"356","author":"Bren-Mattison","year":"2011","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0875","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bone.2004.01.022","article-title":"The \u2018muscle-bone unit\u2019 during the pubertal growth spurt","volume":"34","author":"Rauch","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bbcan.2020.188359_bb0880","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jbmr.1969","article-title":"Bone and skeletal muscle: neighbors with close ties","volume":"28","author":"DiGirolamo","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0885","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1210\/endo.140.12.7195","article-title":"Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats","volume":"140","author":"Liang","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2020.188359_bb0890","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0895","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1359\/JBMR.051203","article-title":"Increased muscle mass with myostatin deficiency improves gains in bone strength with exercise","volume":"21","author":"Hamrick","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0900","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jcp.20757","article-title":"Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism","volume":"209","author":"McFarlane","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0905","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bonekey.2015.59","article-title":"Cancer-associated muscle weakness: What's bone got to do with it?","volume":"4","author":"Waning","year":"2015","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.bbcan.2020.188359_bb0910","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb0915","article-title":"Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness","volume":"5","author":"Hesse","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2020.188359_bb0920","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.3892\/ijo.2013.1893","article-title":"Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin\/+ mouse","volume":"42","author":"Manne","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0925","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cpcardiol.2008.01.002","article-title":"The diagnosis and management of cardiovascular disease in cancer patients","volume":"33","author":"Yusuf","year":"2008","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0930","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/ijc.27594","article-title":"Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer","volume":"131","author":"Imoto","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188359_bb0935","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1172\/JCI128411","article-title":"Neuromuscular junctions are stable in patients with cancer cachexia","volume":"130","author":"Boehm","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2020.188359_bb0940","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djr556","article-title":"Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis","volume":"104","author":"Baldwin","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2020.188359_bb0945","first-page":"6089","article-title":"Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover","volume":"51","author":"Beck","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb0950","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1042\/cs0920215","article-title":"Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6","volume":"92","author":"Wigmore","year":"1997","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbcan.2020.188359_bb0955","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/cncr.25709","article-title":"Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy","volume":"117","author":"Murphy","year":"2011","journal-title":"Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2020.188359_bb0960","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000227411","article-title":"Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia","volume":"51","author":"Von Roenn","year":"1994","journal-title":"Oncology"},{"key":"10.1016\/j.bbcan.2020.188359_bb0965","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004310.pub3","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbcan.2020.188359_bb0970","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clnu.2013.01.004","article-title":"A new look at an old drug for the treatment of cancer cachexia: megestrol acetate","volume":"32","author":"Argiles","year":"2013","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbcan.2020.188359_bb0975","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jama.1987.03390090067026","article-title":"High-dose megestrol acetate. A possible treatment for cachexia","volume":"257","author":"Tchekmedyian","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.bbcan.2020.188359_bb0980","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1023\/A:1011156811739","article-title":"High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomized clinical trials","volume":"12","author":"Maltoni","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0985","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000421-199210000-00008","article-title":"Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study","volume":"15","author":"Feliu","year":"1992","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb0990","doi-asserted-by":"crossref","first-page":"636","DOI":"10.20452\/pamw.510","article-title":"Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome\u2013a systematic review and meta-analysis","volume":"118","author":"Lesniak","year":"2008","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.bbcan.2020.188359_bb0995","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-2002-25268","article-title":"Megestrol acetate to correct the nutritional status in an adolescent with growth hormone deficiency: Increase of appetite and body weight but only by increase of body water and fat mass followed by profound cortisol and testosterone depletion","volume":"214","author":"Schmid","year":"2002","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.bbcan.2020.188359_bb1000","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jcsm.12116","article-title":"Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation","volume":"7","author":"Musolino","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb1005","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0899-9007(99)00007-6","article-title":"Thrombotic events associated with megestrol acetate in patients with AIDS cachexia","volume":"15","author":"Koller","year":"1999","journal-title":"Nutrition"},{"key":"10.1016\/j.bbcan.2020.188359_bb1010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1525-8610(04)70052-3","article-title":"Incidence of venous thromboembolism in megestrol acetate users","volume":"5","author":"Thomas","year":"2004","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.bbcan.2020.188359_bb1015","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","volume":"24","author":"Study","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1025","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1200\/JCO.1999.17.10.3299","article-title":"Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia\/cachexia","volume":"17","author":"Loprinzi","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1634\/theoncologist.2014-0260","article-title":"Effects of Dexamethasone and Placebo on Symptom Clusters in Advanced Cancer Patients: A Preliminary Report","volume":"21","author":"Yennurajalingam","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.bbcan.2020.188359_bb1035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jamda.2010.02.012","article-title":"Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia\/cachexia","volume":"12","author":"Chasen","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.bbcan.2020.188359_bb1040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/gast.2001.22158","article-title":"Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin","volume":"120","author":"Asakawa","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2020.188359_bb1045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/14712598.2013.748031","article-title":"The hunger hormone ghrelin in cachexia","volume":"13","author":"Molfino","year":"2013","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.bbcan.2020.188359_bb1050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","article-title":"Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile","volume":"5","author":"Pietra","year":"2014","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"23","key":"10.1016\/j.bbcan.2020.188359_bb1055","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bbcan.2020.188359_bb1060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/SPC.0000000000000450","article-title":"Cancer cachexia and treatment toxicity","volume":"13","author":"Chowdhry","year":"2019","journal-title":"Curr. Opin. Support Palliat. Care"},{"issue":"4","key":"10.1016\/j.bbcan.2020.188359_bb1065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SPC.0000000000000457","article-title":"From cachexia to obesity: the role of host metabolism in cancer immunotherapy","volume":"13","author":"Brocco","year":"2019","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"10.1016\/j.bbcan.2020.188359_bb1070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ajcn\/66.3.683","volume":"66","author":"Klein","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbcan.2020.188359_bb1075","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2020.188359_bb1080","first-page":"18","article-title":"A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia","volume":"6","author":"Wiedenmann","year":"2008","journal-title":"J. Support Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1085","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1200\/jco.2010.28.15_suppl.7622","article-title":"A.s. group, Efect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II randomized, double-blind safety and efficacy trial","volume":"28","author":"Rigas","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1090","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1200\/jco.2009.27.15_suppl.3025","article-title":"A phase I, pharmacokinetic (PK), and preliminary efficacy assessment of ALD518, a humanized anti-IL-6 antibody, in patients with advanced cancer","volume":"27","author":"Clarke","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1095","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1470-2045(14)70155-X","article-title":"MABp1, a first-in-class true human antibody targeting interleukin-1alpha in refractory cancers: an open-label, phase 1 dose-escalation and expansion study","volume":"15","author":"Hong","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(14)70164-0","article-title":"Interleukin-1alpha neutralisation in patients with cancer","volume":"15","author":"Dinarello","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1105","first-page":"505","article-title":"Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia","volume":"24","author":"Lundholm","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2020.188359_bb1110","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv274","article-title":"Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia","volume":"107","author":"Tseng","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2020.188359_bb1115","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188359_bb1120","doi-asserted-by":"crossref","first-page":"e9910","DOI":"10.15252\/emmm.201809910","article-title":"Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor","volume":"12","author":"Liva","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2020.188359_bb1125","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s12885-016-2424-9","article-title":"Metformin treatment modulates the tumor-induced wasting effects in muscle protein metabolism minimising the cachexia in tumor-bearing rats","volume":"16","author":"Oliveira","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2020.188359_bb1130","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/14656566.8.8.1085","article-title":"Pharmacological options for advanced cancer patients with loss of appetite and weight","volume":"8","author":"Behl","year":"2007","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bbcan.2020.188359_bb1135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bbcan.2020.188359_bb1140","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/1055-9965.EPI-05-0538","article-title":"A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia\/cachexia and oxidative stress","volume":"15","author":"Mantovani","year":"2006","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbcan.2020.188359_bb1145","doi-asserted-by":"crossref","first-page":"12448","DOI":"10.1073\/pnas.1707925114","article-title":"Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy","volume":"114","author":"Morvan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2020.188359_bb1150","article-title":"HASPIN kinase inhibitor CHR-6494 suppresses intestinal polyp development, cachexia, and hypogonadism in Apcmin\/+ mice","author":"Tanaka","year":"2019","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.bbcan.2020.188359_bb1155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13048-019-0586-1","article-title":"Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling","volume":"12","author":"Straughn","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.bbcan.2020.188359_bb1160","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-019-12657-w","article-title":"The TLR7\/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer","volume":"10","author":"Michaelis","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20300159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20300159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:32:39Z","timestamp":1759638759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X20300159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":232,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0304419X20300159"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188359","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"188359"}}